Nairobi West Hospital currently has a bone marrow transplant facility, but it is limited to autologous transplants.
The indolent lymphoma market is witnessing steady growth driven by the increasing prevalence of slow-growing non-Hodgkin ...
Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced a beneficial ...
Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...
MUSCAT: The University Medical City (UMC) launched the Bone Marrow Transplant Unit as part of the National Haematology and ...
MUSCAT: The University Medical City (UMC) launched the Bone Marrow Transplant Unit as part of the National Hematology and ...
CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...
The event will provide clinical perspectives and market outlook for lacutamab, Innate’s lead proprietary product progressing ...
Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the ...
EVERSANA to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...
WNEM Saginaw on MSN
A father's fight: From relapse to remission
Every year, more than 80,000 Americans hear the life-changing words: You have Non-Hodgkin’s Lymphoma. That may not sound like ...
Researchers conducted a systematic review to assess the effect of certain cancer treatments on pregnancy and neonatal outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback